Recruiting
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
NCT07007793
- Conditions
- Adrenal Gland Diseases, Adrenocortical Hyperfunction, Endocrine System Diseases, +2 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States
- Research Site Farmington, Connecticut, United States
- Research Site Chicago, Illinois, United States